Structure Therapeutics is trading 5.03% higher at $22.14 on October 19, 2026; the move appears consistent with a supportive market backdrop, with no verified company-specific announcement explaining it. - Company headline listings showed no October 19 news. - Biotech was up 2.09%, while broader U.S. stocks also rebounded. - Merck KGaA’s announced acquisition of Silence Therapeutics added to biotech M&A optimism, but was an industry catalyst, not a Structure-specific event.